 |
|
Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence
Jordan J Levett, Miltiadis Georgiopoulos, Simon Martel, Wissam Al Mugheiry, Nikolaos A. Stavropoulos, Miguel Vega-Arroyo, Carlo Santaguida, Michael H. Weber, Jeff D. Golan, Peter Jarzem, Jean A. Ouellet, Georgios Klironomos, Andreas K. Demetriades
Neurospine. 2024;21(2):375-400. Published online 2024 Jun 30 DOI: https://doi.org/10.14245/ns.2448140.070
|
|
Citations to this article as recorded by
 Conservative and newer drug treatment for degenerative cervical myelopathy
Osita Ede, Jason Pui Yin Cheung
Journal of Clinical Orthopaedics and Trauma.2025; 64: 102972. CrossRef From the Editor-in-Chief: Featured Articles in the June 2024 Issue
Inbo Han
Neurospine.2024; 21(2): 373. CrossRef Neuroprotection and Neuroregeneration of the Injured Spinal Cord: A Focus on Degenerative Cervical Myelopathy – Commentary on “Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence”
Karlo M. Pedro, Michael G. Fehlings
Neurospine.2024; 21(2): 401. CrossRef
|